{
  "resourceType" : "ValueSet",
  "id" : "2.16.840.1.113883.3.666.5.736",
  "meta" : {
    "versionId" : "33",
    "lastUpdated" : "2023-12-21T17:43:03.000-05:00",
    "profile" : [
      "http://hl7.org/fhir/StructureDefinition/shareablevalueset",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/computable-valueset-cqfm",
      "http://hl7.org/fhir/us/cqfmeasures/StructureDefinition/publishable-valueset-cqfm"
    ]
  },
  "extension" : [
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-author",
      "valueString" : "Lantana EH Author"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/resource-lastReviewDate",
      "valueDate" : "2024-06-03"
    },
    {
      "url" : "http://hl7.org/fhir/StructureDefinition/valueset-effectiveDate",
      "valueDate" : "2017-05-04"
    }
  ],
  "url" : "http://cts.nlm.nih.gov/fhir/ValueSet/2.16.840.1.113883.3.666.5.736",
  "identifier" : [
    {
      "system" : "urn:ietf:rfc:3986",
      "value" : "urn:oid:2.16.840.1.113883.3.666.5.736"
    }
  ],
  "version" : "20170504",
  "name" : "FibrinolyticTherapy",
  "title" : "Fibrinolytic Therapy",
  "status" : "retired",
  "experimental" : false,
  "date" : "2017-05-04T01:00:13-04:00",
  "publisher" : "Lantana EH Steward",
  "jurisdiction" : [
    {
      "coding" : [
        {
          "system" : "urn:iso:std:iso:3166",
          "code" : "US"
        }
      ]
    }
  ],
  "purpose" : "(Clinical Focus: This value set contains concepts that represent medications that are prescribed for fibrinolytic therapy in patients with an episode of acute myocardial infarction.),(Data Element Scope: This value set may use the Quality Data Model (QDM) datatype related to Medication, Administered. The intent of this data element is to identify patients who are prescribed fibrinolytic therapy during an episode of an acute myocardial infarction.),(Inclusion Criteria: Includes only relevant concepts associated with generic and prescribable fibrinolytic agents. Only injectable dose forms should be included. Single ingredient.),(Exclusion Criteria: No exclusions.)",
  "compose" : {
    "include" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "concept" : [
          {
            "code" : "1804799",
            "display" : "alteplase 100 MG Injection"
          },
          {
            "code" : "1804804",
            "display" : "alteplase 50 MG Injection"
          },
          {
            "code" : "313212",
            "display" : "Tenecteplase 50 MG Injection"
          },
          {
            "code" : "763138",
            "display" : "Reteplase 1 UNT/ML Injectable Solution"
          }
        ]
      }
    ]
  },
  "expansion" : {
    "identifier" : "urn:uuid:5b03759d-097b-4eae-a42a-b5ae7cdaf4f5",
    "timestamp" : "2024-06-14T18:02:25-04:00",
    "total" : 4,
    "contains" : [
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1804799",
        "display" : "alteplase 100 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "1804804",
        "display" : "alteplase 50 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "313212",
        "display" : "tenecteplase 50 MG Injection"
      },
      {
        "system" : "http://www.nlm.nih.gov/research/umls/rxnorm",
        "version" : "05062024",
        "code" : "763138",
        "display" : "reteplase 10 UNT Injection"
      }
    ]
  }
}
